Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Kono

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|April 3, 2007
Contemporary empyema necessitatisScott A Kono, Trenton D Nauser
Chemotherapy Research and Practice|October 12, 2012
EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond CetuximabScott A Kono, Missak Haigentz, Sue S Yom, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 9, 2009
The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancerScott A Kono, Marianne E Marshall, Kathryn E Ware, et al.
Oncology (Williston Park, N.Y.)|May 30, 2009
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLCScott A Kono, Michael Weyant, Wilbur Franklin, et al.
Complementary Therapies in Clinical Practice|December 10, 2014
Patients' perceptions of complementary and alternative medicine in head and neck cancer: a qualitative, pilot study with clinical implicationsKristopher A Hendershot, Margie Dixon, Scott A Kono, et al.
Head and Neck Pathology|April 25, 2012
HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases?Susan Müller, Fadlo R Khuri, Scott A Kono, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2012
Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysisMadhusmita Behera, Taofeek K Owonikoko, Zhengjia Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2010
Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatmentD Ross Camidge, Scott A Kono, Antonella Flacco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cellsMarianne E Marshall, Trista K Hinz, Scott A Kono, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 22, 2011
Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexedD Ross Camidge, Scott A Kono, Xian Lu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|April 3, 2007
Contemporary empyema necessitatisScott A Kono, Trenton D Nauser
Chemotherapy Research and Practice|October 12, 2012
EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond CetuximabScott A Kono, Missak Haigentz, Sue S Yom, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 9, 2009
The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancerScott A Kono, Marianne E Marshall, Kathryn E Ware, et al.
Oncology (Williston Park, N.Y.)|May 30, 2009
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLCScott A Kono, Michael Weyant, Wilbur Franklin, et al.
Complementary Therapies in Clinical Practice|December 10, 2014
Patients' perceptions of complementary and alternative medicine in head and neck cancer: a qualitative, pilot study with clinical implicationsKristopher A Hendershot, Margie Dixon, Scott A Kono, et al.
Head and Neck Pathology|April 25, 2012
HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases?Susan Müller, Fadlo R Khuri, Scott A Kono, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2012
Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysisMadhusmita Behera, Taofeek K Owonikoko, Zhengjia Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2010
Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatmentD Ross Camidge, Scott A Kono, Antonella Flacco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cellsMarianne E Marshall, Trista K Hinz, Scott A Kono, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 22, 2011
Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexedD Ross Camidge, Scott A Kono, Xian Lu, et al.
Pageof 2